Merkel Cell Carcinoma

 

Interleukin-12 by Electroporation for Merkel Cell Carcinoma
A Phase II Study of Intratumoral Injection of Interleukin-12 Plasmid and in Vivo Electroporation in Patients With Merkel Cell Carcinoma

Investigator: Shailender Bhatia, M.D.;   Conditions: Merkel Cell Carcinoma;    Status: Recruiting;   Study ID: NCT01440816

Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma (2586)
Study to Evaluate Cellular Adoptive Immunotherapy Using Polyclonal Autologous CD8+ Antigen-Specific T Cells for Metastatic Merkel Cell Carcinoma

Investigator: Aude Chapuis, MD;   Conditions: Merkel Cell Carcinoma;    Status: Recruiting;   Study ID: NCT01758458